AndersonR.J.SchaferL.A.OlinD.B.EickhoffT.C.Infectious risk factors in the immunosuppressed host.Am. J. Med.54: 453–460; 1973.
2.
BeamonM.H.McCabeR.E.WongS.-Y.RemingtonJ.S.Toxoplasma gondii. In: MandellG.L.BennettJ.E. eds. Principles and practice of infectious diseases.New York: Churchill-Livingston;1995: 2455–2475.
3.
BranchD.W.DucatL.FantelA.LowW.C.ZhouF.C.DaytonD.H.GillT.J.for The Human Fetal Tissue Working Group. Suitability of fetal tissues from spontaneous abortions and from ectopic pregnancies for transplantation.JAMA273: 66–68; 1995.
4.
ConeR.W.HobsonA.C.BrownZ.: AshleyR.BerryS.WinterC.CoreyL.Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women.JAMA272: 792–796; 1994.
5.
DunnD.L.NajarianJ.S.New approaches to the diagnosis, prevention, and treatment of cytomegalovirus infection after transplantation.Am. J. Surg.161: 250–255; 1991.
6.
Food and Drug Administration.Good laboratory practice for nonclinical laboratory studies.FDA/21 CFR Part 58, 1-19, 1981.
7.
FreedC.R.BreezeR.E.RosenbergN.L.SchneckS.A.WellsT.H.BarrettJ.N.GraftonS.T.HuangS.C.EidelbergD.RottenbergD.A.Transplantation of human fetal dopamine cells for Parkinson's disease.Arch. Neurol.47: 505–512; 1990.
8.
FreedC.R.BreezeR.E.RosenbergN.L.SchneckS.A.KriekE.Jian-XinQ.LoneT.ZhangY-B.SnyderJ.A.WellsT.H.RamigL.O.ThompsonL.MazziottaJ.C.HuangS.C.GraftonS.T.BrooksD.SawleG.SchroterG.AnsariA.A.Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.N. Engl. J. Med.327: 1549–1555; 1992.
9.
FreemanT.B.KordowerJ.H.Human cadaver embryonic substantia nigra grafts: Effects of ontogeny, preoperative graft preparation and tissue storage. In: LindvallO.BjorklundA.WidnerH. eds. Intracerebral transplantation in movement disorders: Experimental basis and clinical experience.Amsterdam: Fernstrom Foundation Series, Elsevier Science Publishers, B.V.; 1991:15: 163–169.
10.
FreemanT.B.OlanowC.W.Fetal homotransplants in the treatment of Parkinson's disease.Arch. Neurol.48: 900–901; 1991.
11.
FreemanT.B.OlanowC.W.HauserR.A.KordowerJ.H.HoltD.BorlonganC.V.SanbergP.R.Human fetal transplantation for the treatment of movement disorders. In: GermanoI.M. ed. Neurosurgical treatment of movement disorders.New York: AANS Publications; 1998: (in press).
12.
FreemanT.B.OlanowC.W.HauserR.A.NauertM.SmithD.A.BorlonganC.V.SanbergP.R.HoltD.A.KordowerJ.H.VingerhoetsF.J.G.SnowB.J.CalneD.GaugerL.L.Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease.Ann. Neurol.38: 379–388; 1995.
13.
GottesdianerK.M.Transplant infections: Donor-to-host transmission with allograft.Ann. Intern. Med.110: 1001–1016; 1989.
14.
HendersonB.T.H.CloughC.G.HughesR.C.HitchcockE.R.KennyB.G.Implantation of human fetal ventral mesencephalon to the right caudate nucelus in advanced Parkinson's disease.Arch. Neurol.48: 822–827; 1991.
15.
KeatingM.R.WilhelmM.P.WalkerR.C.Strategies for prevention of infection after cardiac transplantation.Mayo Clin. Proc.67: 676–684; 1992.
16.
KopyovO.V.JacquesD.LiebermanA.DumaC.M.RogersR.Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease.Cell Transplant.5: 327–337; 1996.
17.
LindvallO.RehncronaS.BrundinP.GustaviiB.AstedtB.WidnerH.LindholmT.BjorklundA.LeendersK.L.RothwellJ.C.FrackowiakR.MarsdenC.D.JohnelsB.StegG.FreedmanR.HofferB.J.SeigerA.BygdemanM.StrombergI.OlsonL.Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: A detailed account of methodology and a 6-month follow-up.Arch. Neurol.46: 615–631; 1989.
18.
LindvallO.BrundinP.WidnerH.RehncronaS.GustaviiB.FrackowiakR.LeendersK.L.SawleG.RothwellJ.C.MarsdenC.D.BjorklundA.Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.Science247: 574–577; 1990.
19.
MadrazoI.Franco-BourlandR.Ostrosky-SolisF.AguileraM.CuevasC.ZamoranoC.MorelosA.MagallonE.Guizar-SahagunG.Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of Parkinsonian subjects.Arch. Neurol.47: 1281–1285; 1990.
20.
MoranS.Stopping the flow of tainted blood.Insight14-18: 8/2/93.
21.
MortierE.PouchotJ.BossiP.MolinieV.Maternal–fetal transmission of Pneumocystis carinae in human immunodeficiency virus infection.N. Engl. J. Med.332: 825; 1995.
22.
NauertG.M.FreemanT.B.Low-pressure abortion for obtaining embryonic and early gestational fetal tissue for research purposes.Cell Transplant.3: 147–151; 1994.
23.
OlanowC.W.KordowerJ.H.FreemanT.B.Fetal nigral transplantation as a therapy for Parkinson's disease.Trends Neurosci.19: 102–109; 1996.
24.
ProberC.G.HensleighP.A.BoucherF.D.YasukawaL.L.AuD.S.ArvinA.M.Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus.N. Engl. J. Med.318: 887–891; 1988.
25.
RobbinsR.J.Torres-AlemanI.LeranthC.BradberryC.W.DeutchA.Y.WelshS.RothR.H.SpencerD.RedmondD.E.Jr.NaftolinF.Cryopreservation of human brain tissue.Exp. Neurol.107: 208–213; 1990.
26.
RubinR.H.Indirect effects of cytomegalovirus infection on the outcome of organ transplantation.JAMA261: 3607; 1989.
27.
RubinR.H.Infection in the organ transplant recipient. In: RubinR.H.YoungL.S. eds. Clinical approach to infection in the compromised host, 3rd ed.New York: Plenum Press; 1994: 629–705.
28.
RubinR.H.Tolkoff-RubinN.E.The problem of human immunodeficiency virus infection and transplantation.Transplant. Int.1: 36; 1988.
29.
SeverJ.L.Infectious causes of human reproductive loss. In: PorterI.H.HookB. eds. Human embryonic and fetal death.New York: Academic Press; 1980: 169–175.
30.
SpencerD.D.RobbinsR.J.NaftolinF.MarekK.L.VollmerT.LeranthC.RothR.H.PriceL.H.GieddeA.BunneyB.S.SassK.J.ElsworthJ.D.KierE.L.MakuchR.HofferP.B.RedmondD.E.Jr.Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.N. Engl. J. Med.327: 1541–1548; 1992.
31.
TaylorG.D.KirklandT.LakeyJ.RajotteR.WarnockG.L.Bacteremia due to transplantation of contaminated cryopreserved pancreatic islets.Cell Transplant.3: 103–106; 1994.
32.
WidnerH.TetradJ.RehncronaS.Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).N. Engl. J. Med.327: 1556–1563; 1992.
33.
ZabekM.MazurowskiW.DymeckiJ.StelmachowJ.ZawadaE.A long term follow-up of fetal dopaminergic neurons transplantation into the brain of three parkinsonian patients.Restor. Neurol. Neurosci.6: 97–106; 1994.